Table 2.
Antimicrobial resistance profiles of 39 Vibrio parahaemolyticus isolates.
| Antimicrobial agent | Vibrio parahaemolyticus (n = 39) | ||
|---|---|---|---|
| NO.(%) of R | NO.(%) of I | NO.(%) of S | |
| Ampicillin (AMP) | 20 (51.3) | 14 (35.9) | 5 (12.8) |
| Azitromycin (AZM) | 0 (0.0) | 14 (35.9) | 25 (64.1) |
| Cefazolin (KZ) | 20 (51.3) | 18 (46.1) | 1 (2.6) |
| Cephalothin (KF) | 16 (41.0) | 22 (56.4) | 1 (2.6) |
| Chloramphenicol (C) | 0 (0.0) | 1 (2.6) | 38 (97.4) |
| Ciprofloxacin (CIP) | 0 (0.0) | 13 (33.3) | 26 (66.7) |
| Gentamicin (CN) | 1 (2.6) | 18 (46.1) | 20 (51.3) |
| Kanamycin (K) | 16 (41.0) | 20 (51.3) | 3 (7.7) |
| Nalidixic acid (NA) | 0 (0.0) | 2 (5.1) | 37 (94.9) |
| Streptomycin (S) | 35 (89.7) | 4 (10.3) | 0 (0.0) |
| Trimethoprim-sulfamethoxazole (SXT) | 1 (2.6) | 4 (10.3) | 34 (87.1) |
| Tetracycline (TE) | 0 (0.0) | 4 (10.3) | 35 (89.7) |
*R, resistant; I, intermediate resistance; S, susceptibility.